Overactive bladder drugs on Prescription Blue Premium (S5584-002)
Oxybutynin, solifenacin, Myrbetriq and Gemtesa, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Michigan
- Premium
- $106.70/month
- Deductible
- None
5 of 7 Overactive bladder drugs are covered on this plan. None require prior authorization.
2 aren't on the formulary (mirabegron and trospium).
- from $3.24Tier 3
- from $2.19Tier 3
- from $104.24Tier 3
- $131.30Tier 4
- from $6.05Tier 4
Not on the formulary
mirabegron, trospium
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.